Ataluren
Back to searchMolecule Structure
Scientific Name
Ataluren
Description of the Drug
Ataluren is a medication used for the treatment of Duchenne muscular dystrophy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05016
http://www.drugbank.ca/drugs/DB05016
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| 80S Ribosome | PROTEIN NUCLEIC-ACID COMPLEX | MODULATOR | CHEMBL3987582 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL60614 |
| PharmGKB | PA166151864 |
| Human Metabolome Database | HMDB0248691 |
| DrugBank | DB05016 |
| PubChem: Thomson Pharma | 16302894 |
| PubChem | 11219835 |
| LINCS | LSM-5991 |
| Nikkaji | J2.446.661B |
| PDBe | JBF |
| EPA CompTox Dashboard | DTXSID5046776 |
| DrugCentral | 4872 |
| Brenda | 101241 |
| ChemicalBook | CB02128667 |
| Guide to Pharmacology | 7341 |
| PubChem: Drugs of the Future | 57304410 |
| ChEBI | 94805 |
| ZINC | ZINC000013831791 |
